TrialPath

17 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

15 studies on the map

Concomitant Renal and Urinary Bladder Allograft Transplantation — Mayo Clinic, RochesterSubclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease — Brigham and Women's Hospital, BostonOral Intradialytic Amino Acid Supplementation to Vitalize End-stage Kidney Disease Patients on Hemodialysis — The University of Texas Health Science Center at San Antonio, San AntonioFeasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease — Ann & Robert H. Lurie Children's Hospital of Chicago, ChicagoProbiotic Administration for Adolescent Depression — UCSF, San FranciscoMood Effects of Serotonin Agonists: Depression — University of Chicago, ChicagoGlutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With Ketamine — Emory University, AtlantaA Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression — UCLA Semel Institute - Neuropsychiatric Institute (NPI), Los AngelesSynaptic Mechanisms of Continuous Theta Burst Stimulation in Depression — McLean Hospital, BelmontConfirmatory Efficacy Trial of Attention Bias Modification for Depression — Institute for Mental Health Research, AustinPilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine — University of Pennsylvania, PhiladelphiaPsilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease — Johns Hopkins Center for Psychedelic and Consciousness Research, Baltimore68Ga-FAPI-46 PET/CT for Assessing Small Bowel Fibrostenosis in Crohn's Disease — Mayo Clinic, RochesterEffect of Statins on Crohn's Disease — Stanford University, StanfordStatin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study — Stanford University, Stanford